Abstract
Osteosarcoma is a radioresistant tumor. There have been few reports on the effectiveness of radiotherapy for unresectable osteosarcoma using photon (X-ray) beams. Carbon ion beams have a unique physical advantage for avoiding irradiation of critical organs, and their biological effectiveness is higher than that of X-ray and proton beams. These specific characteristics are beneficial for the treatment of sarcomas. Carbon ion radiotherapy has thus been suggested as an effective local therapy for unresectable osteosarcoma of the trunk.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Goorin AM, Schwartzentruber DJ, Devidas M, Gebhardt MC, Ayala AG, Harris MB, Helman LJ, Grier HE, Link MP, Pediatric Oncology Group. Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group Study POG-8651. J Clin Oncol. 2003;21:1574–80.
Eilber F, Giuliano A, Eckardt J, Patterson K, Moseley S, Goodnight J. Adjuvant chemotherapy for osteosarcoma: a randomized prospective trial. J Clin Oncol. 1987;5:21–6.
Bielack SS, Kempf-Bielack B, Delling G, Exner GU, Flege S, Helmke K, Kotz R, Salzer-Kuntschik M, et al. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1702 patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. J Clin Oncol. 2002;20:776–90.
Ozaki T, Flege S, Kevric M, Lindner N, Maas R, Delling G, Schwarz R, von Hochstetter AR, et al. Osteosarcoma of the pelvis: experience of the Cooperative Osteosarcoma Study Group. J Clin Oncol. 2003;21:334–41.
Ozaki T, Flege S, Liljenqvist U, Hillmann A, Delling G, Salzer-Kuntschik M, Jürgens H, Kotz R, et al. Osteosarcoma of the spine: experience of the Cooperative Osteosarcoma Study group. Cancer. 2002;94:1069–77.
Ferrari S, Palmerini E, Fabbri N, Staals E, Ferrari C, Alberghini M, Picci P. Osteosarcoma of the pelvis: a monoinstitutional experience in patients younger than 41 years. Tumori. 2012;98:702–8.
Hundsdoerfer P, Albrecht M, Rühl U, Fengler R, Kulozik AE, Henze G. Long-term outcome after polychemotherapy and intensive local radiation therapy of high-grade osteosarcoma. Eur J Cancer. 2009;45:2447–51.
Bragg WH, Kleeman R. On the ionization curves of radium. Philos Mag. 1904;S6:726–38.
Lawrence JH, Tobias CA, Born JL, McCombs RK, Roberts JE, Anger HO, Lowbeer BV, Huggins CB. Pituitary irradiation with high-energy proton beams: a preliminary report. Cancer Res. 1958;18:121–34.
Tsujii H. History of charged particle radiotherapy. In: Tsujii H, Kamada T, Shirai T, editors. Carbon-ion radiotherapy principles, practices, and treatment planning. Japan: Springer; 2014. p. 3–10.
Tsujii H, Tsuji H, Inada T, et al. Clinical results of fractionated proton therapy. Int J Radiat Oncol Biol Phys. 1993;25:49–60.
Castro JR, Saunders WM, Tobias CA, Chen GT, Curtis S, Lyman JT, Collier JM, Pitluck S. Treatment of cancer with heavy charged particles. Int J Radiat Oncol Biol Phys. 1982;8:2191–8.
Linstadt DE, Castro JR, Phillips TL. Neon ion radiotherapy: results of the phase I/II clinical trial. Int J Radiat Oncol Biol Phys. 1991;20:761–9.
Facilities in Operation. Particle Therapy Co-Operative Group. http://www.ptcog.ch/. Accessed Dec 2013.
Kamada T. The characteristic of carbon ion radiotherapy. In: Tsujii H, Kamada T, Shirai T, editors. Carbon-ion radiotherapy principles, practices, and treatment planning. Japan: Springer; 2014. p. 13–6.
Yonai S, Furukawa T, Inaniwa T. Measurement of neutron ambient dose equivalent in carbon-ion radiotherapy with an active scanned delivery system. Radiat Prot Dosim. 2014;161:433–6.
Kamada T, Tsujii H, Tsuji H, Yanagi T, Mizoe JE, Miyamoto T, Kato H, Yamada S, et al. Efficacy and safety of carbon ion radiotherapy in bone and soft tissue sarcomas. J Clin Oncol. 2002;20:4466–71.
Matsumoto K, Imai R, Kamada T, Maruyama K, Tsuji H, Tsujii H, Shioyama Y, Honda H, et al. Impact of carbon ion radiotherapy for primary spinal sarcoma. Cancer. 2013;119:3496–503.
Hug EB, Adams J, Fitzek M, De Vries A, Munzenrider JE. Fractionated, three-dimensional, planning-assisted proton-radiation therapy for orbital rhabdomyosarcoma: a novel technique. Int J Radiat Oncol Biol Phys. 2000;47:979–84.
Imai R, Kamada T, Tsuji H, Tsujii H, Tsuburai Y, Tatezaki S, Working Group for Bone and Soft Tissue Sarcomas. Cervical spine osteosarcoma treated with carbon-ion radiotherapy. Lancet Oncol. 2006;7:1034–5.
Fukumoto T, Komatsu S, Hori Y, Murakami M, Hishikawa Y, Ku Y. Particle beam radiotherapy with a surgical spacer placement for advanced abdominal leiomyosarcoma results in a significant clinical benefit. J Surg Oncol. 2010;101:97–9.
Rutz HP, Weber DC, Sugahara S, Timmermann B, Lomax AJ, Bolsi A, Pedroni E, Coray A, et al. Extracranial chordoma: outcome in patients treated with function-preserving surgery followed by spot-scanning proton beam irradiation. Int J Radiat Oncol Biol Phys. 2007;67:512–20.
Matsunobu A, Imai R, Kamada T, Imaizumi T, Tsuji H, Tsujii H, Shioyama Y, Honda H, et al. Impact of carbon ion radiotherapy for unresectable osteosarcoma of the trunk. Cancer. 2012;118:4555–63.
Kawai A, Huvos AG, Meyers PA, Healey JH. Osteosarcoma of the pelvis. Oncologic results of 40 patients. Clin Orthop Relat Res. 1998;348:196–207.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Japan
About this chapter
Cite this chapter
Imai, R., Kamada, T. (2016). Carbon Ion Radiotherapy for Unresectable Osteosarcoma of the Trunk. In: Ueda, T., Kawai, A. (eds) Osteosarcoma. Springer, Tokyo. https://doi.org/10.1007/978-4-431-55696-1_18
Download citation
DOI: https://doi.org/10.1007/978-4-431-55696-1_18
Published:
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-55695-4
Online ISBN: 978-4-431-55696-1
eBook Packages: MedicineMedicine (R0)